Last updated: November 21, 2026
The top pharmaceutical companies in Mumbai for 2027 are Sun Pharmaceutical Industries, Cipla, Lupin, Glenmark Pharmaceuticals and Alkem Laboratories, followed by Piramal Pharma, Ipca Laboratories, J.B. Chemicals & Pharmaceuticals, Wockhardt and Abbott India. All ten are headquartered in Mumbai, and together they make the city the corporate capital of India’s pharmaceutical industry, the world’s largest supplier of generic medicines by volume.
Most of these companies manufacture in Gujarat, Goa, Himachal Pradesh, Sikkim and other states, and many have plants and research centers abroad, but their leadership, finance, regulatory, marketing and commercial teams sit in Mumbai. That concentration makes the city a hub for pharma careers, suppliers, contract research and manufacturing partners, and investors following one of India’s most globally competitive sectors.
This list profiles the companies themselves and is not medical or investment advice. We researched each company on its own website, annual reports and public information as of November 2026. For the city’s wider business scene, see our Top Startups In Mumbai list.
| Company | Founded | Main Strengths | Known For |
|---|---|---|---|
| Sun Pharmaceutical Industries | 1983 | Specialty medicines and generics | India’s largest pharma company by revenue |
| Cipla | 1935 | Respiratory, generics and anti-infectives | Affordable HIV medicines and inhalers |
| Lupin | 1968 | US generics, respiratory and anti-TB | Large US generics business |
| Glenmark Pharmaceuticals | 1977 | Dermatology, respiratory and oncology | Innovation-led branded generics |
| Alkem Laboratories | 1973 | Acute therapies in India | Leading domestic brands |
| Piramal Pharma | Part of Piramal Group | Contract development and manufacturing | CDMO and critical care |
| Ipca Laboratories | 1949 | Pain, anti-malarials and APIs | Vertically integrated manufacturing |
| J.B. Chemicals & Pharmaceuticals | 1976 | Cardiac and chronic therapies | Strong domestic brands |
| Wockhardt | 1960s | Antibiotics research and generics | New antibiotic development |
| Abbott India | Subsidiary of Abbott | Branded generics | Thyroid and women’s health brands |
Sun Pharmaceutical Industries, founded in 1983 by Dilip Shanghvi, is India’s largest pharmaceutical company by revenue and one of the largest specialty generics companies in the world. Headquartered in Mumbai, it sells medicines in more than 100 countries and has a large manufacturing network in India and abroad.
Over the last decade it has built a global specialty business with its own innovative brands in dermatology, ophthalmology and oncology, alongside its large generics portfolio. In India it is the market leader, with strong positions in chronic therapies such as cardiology, neurology and diabetes. Its scale makes it one of the largest pharma employers in the country.
Known for: Scale, specialty brands and leadership in the Indian market.
Cipla was founded in 1935 by Dr. K. A. Hamied and is headquartered in Mumbai. It is best known worldwide for making low-cost antiretroviral medicines that transformed HIV treatment in Africa in the early 2000s, and in India for its leadership in respiratory care, including inhalers for asthma and COPD.
Today it sells in India, the US, South Africa and many emerging markets, with a growing focus on complex generics and respiratory products.
Known for: Inhalers, HIV medicines and access to affordable treatment.
Lupin was founded in 1968 by Dr. Desh Bandhu Gupta and is headquartered in Mumbai. It began with anti-tuberculosis medicines, where it remains a leader, and has grown into one of the largest Indian generics suppliers to the US market, along with strong businesses in India and other countries.
It has invested heavily in complex generics, inhalation products and biosimilars.
Known for: US generics, respiratory products and anti-TB medicines.
Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, is known for dermatology, respiratory and oncology medicines. It sells branded generics in India and emerging markets, generics in the US and Europe, and its own branded products, including a nasal spray for allergies sold in many countries.
Known for: Dermatology and respiratory brands with an innovation focus.
Alkem Laboratories, founded in 1973 and headquartered in Mumbai, is one of the largest pharmaceutical companies in the Indian domestic market. It is especially strong in acute therapies such as anti-infectives, gastrointestinal medicines and pain relief, and it also exports generics to the US and other markets.
Known for: Widely prescribed brands in India.
Piramal Pharma, part of the Mumbai-based Piramal Group, runs one of India’s largest contract development and manufacturing businesses, making drug substances and finished products for pharmaceutical companies around the world. It also has a critical care business, including inhalation anesthetics, and an Indian consumer health business.
Known for: Manufacturing partner to global drug companies.
Ipca Laboratories, founded in 1949 and headquartered in Mumbai, makes both active pharmaceutical ingredients and finished medicines. It is known for pain management, anti-malarial and cardiovascular products, and its integrated manufacturing gives it control over cost and supply.
Known for: APIs and formulations made in-house.
J.B. Chemicals & Pharmaceuticals, founded in 1976 and headquartered in Mumbai, is a fast-growing company in the Indian market with strong brands in cardiology and other chronic therapies. It also exports to Russia, South Africa, the US and other markets and offers contract manufacturing of lozenges.
Known for: Leading cardiac brands in India.
Wockhardt is a Mumbai pharmaceutical and biotechnology company led by Dr. Habil Khorakiwala. It has focused much of its research on new antibiotics designed to treat drug-resistant infections, one of the most pressing problems in global health, alongside generics and biosimilars.
Known for: Research into antibiotics for resistant infections.
Abbott India is the listed Indian subsidiary of US healthcare company Abbott, headquartered in Mumbai. It sells branded generic medicines across women’s health, gastroenterology, thyroid, pain and other areas, and several of its brands are among the most prescribed in India.
Known for: Trusted brands in thyroid and women’s health.
Job seekers should look at therapy areas, research investment and culture. Companies seeking a manufacturing or licensing partner should look at regulatory track record and capacity. Suppliers should understand procurement processes, quality standards and payment terms.
Plants that export to the US and Europe are inspected by the US FDA, the European Medicines Agency and other regulators. Warning letters and import alerts are public, and they matter a great deal for partners and investors.
Some companies earn most of their revenue in India, while others depend on the US or emerging markets. Market mix shapes growth, pricing pressure and the kind of roles and partnerships available.
Research spending, the pipeline of complex generics, biosimilars and new drugs, and the number of patents filed show how a company plans to grow beyond simple generics.
Field sales, manufacturing, research and corporate roles offer very different experiences. Speak to current employees, read reviews and ask about training and career paths.
Ask partners about their quality systems, data integrity controls and audit results. For contract manufacturing in particular, the partner’s compliance becomes part of your own regulatory risk.
For development and manufacturing partnerships, ask about capacity, technology transfer experience and how the company has handled supply disruptions. Agree milestones and penalties before you sign.
Distributors, stockists and pharmacies should look at credit terms, return policies for expired stock and the strength of the company’s brands with doctors. These terms shape working capital and margins far more than headline discounts.
Several Mumbai pharma companies run research and development centers in and around the city, including in Navi Mumbai, Thane and the Andheri and Goregaon areas, alongside larger centers in Gujarat, Pune and abroad. If you are a scientist or a research partner, ask where formulation development, analytical work, clinical research and biologics are actually based, because roles and collaborations follow the labs, not the head office.
Large pharma companies publish sustainability and business responsibility reports covering emissions, water use, waste, product quality and access to medicines. These reports are useful for partners, investors and job seekers who care about how a company manages its environmental footprint and whether it makes treatments available in lower-income markets.
Many Mumbai pharma companies are still led by founding families, while others are owned by private equity investors or multinational parents. Ownership shapes strategy, risk appetite and how decisions are made. Check recent changes in leadership, ownership and strategy before entering a long-term partnership.
Some companies actively partner with health startups, contract research organizations and academic labs through licensing deals, innovation programs and outsourced research. If you run a smaller company, look for public partnership announcements and dedicated business development teams.
Market share data, prescription rankings and regulatory inspection histories are published regularly by industry trackers and regulators. Use them alongside company reports to get a balanced view of each company’s position and momentum.
We looked at pharmaceutical companies headquartered in Mumbai and compared them on scale, therapeutic strengths, global reach, research investment, regulatory track record and influence on the Indian and global pharmaceutical industry. We checked each company on its own website and public information as of November 2026. This list is not medical or investment advice, and no company paid to be included or to change its position. Read more about how we research and rank.
For 2027 our top picks are Sun Pharmaceutical Industries, Cipla, Lupin, Glenmark Pharmaceuticals and Alkem Laboratories, followed by Piramal Pharma, Ipca Laboratories, J.B. Chemicals & Pharmaceuticals, Wockhardt and Abbott India.
Sun Pharmaceutical Industries is the largest pharmaceutical company headquartered in Mumbai and the largest in India by revenue.
Mumbai offers access to capital markets, investors, regulators, a deep pool of finance and marketing talent, and global connections, so many companies keep their headquarters there even though most manufacturing is in other states.
Mostly not. Their main plants are in states such as Gujarat, Goa, Himachal Pradesh, Sikkim and Madhya Pradesh, and abroad, while Mumbai hosts headquarters and some research centers.
Sun Pharma, Cipla and Lupin are the largest and most global of Mumbai’s pharmaceutical companies, Glenmark and Alkem lead in their therapy areas, and Piramal Pharma is a key manufacturing partner for drug companies worldwide. Ipca, J.B. Chemicals, Wockhardt and Abbott India round out the list. For more Mumbai companies and guides, visit our India hub.